Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...

Investors in Eli Lilly (Symbol: LLY) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...

Shares of Eli Lilly & Co. dropped over 7% on Tuesday morning ... bullish,’ with the ticker climbing to the top five trending symbols list amid a spike in message volume. Many retail investors ...

At Holdings Channel, we have reviewed the latest batch of the 31 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Eli Lilly (Symbol: LLY) was held by 22 of these funds.

Eli Lilly's sales growth is coming short of expectations, which is a problem considering its valuation. The company does have a vast lineup and a deep pipeline that go beyond diabetes and obesity.

Eli Lilly and Company (LLY) stock price is 811.08 and Eli Lilly and Company (LLY) 10-day simple moving average is 777.21. Eli Lilly and Company (LLY) stock price is 811.08 and Eli Lilly and ...